Viibryd

Viibryd

  • March 2019 •
  • 17 pages •
  • Report ID: 5807967 •
  • Format: PDF
Viibryd (vilazodone; Allergan) belongs to a new class of antidepressants, combining selective serotonin reuptake inhibitor activity with partial 5-HT1A receptor agonism, in order to produce its therapeutic effect.